EPITOPE TYPE-SPECIFIC IGG RESPONSES TO CAPSID PROTEINS VP1 AND VP2 OF HUMAN PARVOVIRUS B19

被引:104
作者
SODERLUND, M [1 ]
BROWN, CS [1 ]
SPAAN, WJM [1 ]
HEDMAN, L [1 ]
HEDMAN, K [1 ]
机构
[1] LEIDEN UNIV HOSP, DEPT VIROL, LEIDEN, NETHERLANDS
基金
芬兰科学院;
关键词
D O I
10.1093/infdis/172.6.1431
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Temporal reactivities of IgG towards native and linear antigenic determinants in assembled capsids or isolated structural proteins of human parvovirus B19 were measured by an epitope type-specific IgG EIA and by immunoblots, Antigens used were baculovirus-expressed B19 capsids composed of the proteins VP1 and VP2 in their native proportion, VP2 alone, or a prokaryotic VP1 fusion protein. Follow-up sera after primary infection were compared with samples from previously infected persons. The IgG responses during acute and early convalescence phases were directed towards both conformational and linear epitopes of VP2. The antibodies against the linear VP2 epitopes disappeared abruptly within 6 months; however, the conformational VP2 antibodies persisted. The epitope type-specific IgG reactivity of VP1 was strikingly different from that of VP2. On the basis of these results, two novel tests were developed for patient diagnosis. Both tests are suitable for verifying the time of human parvovirus infection.
引用
收藏
页码:1431 / 1436
页数:6
相关论文
共 40 条
[1]   HUMAN PARVOVIRUS INFECTION IN PREGNANCY AND HYDROPS-FETALIS [J].
ANAND, A ;
GRAY, ES ;
BROWN, T ;
CLEWLEY, JP ;
COHEN, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (04) :183-186
[2]   DETECTION OF ANTIBODIES AND ANTIGENS OF HUMAN PARVOVIRUS B19 BY ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
ANDERSON, LJ ;
TSOU, C ;
PARKER, RA ;
CHORBA, TL ;
WULFF, H ;
TATTERSALL, P ;
MORTIMER, PP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1986, 24 (04) :522-526
[3]   AN OUTBREAK OF ERYTHEMA INFECTIOSUM ASSOCIATED WITH HUMAN PARVOVIRUS INFECTION [J].
ANDERSON, MJ ;
LEWIS, E ;
KIDD, IM ;
HALL, SM ;
COHEN, BJ .
JOURNAL OF HYGIENE, 1984, 93 (01) :85-93
[4]   CANDIDATE RECOMBINANT VACCINE FOR HUMAN B19-PARVOVIRUS [J].
BANSAL, GP ;
HATFIELD, JA ;
DUNN, FE ;
KRAMER, AA ;
BRADY, F ;
RIGGIN, CH ;
COLLETT, MS ;
YOSHIMOTO, K ;
KAJIGAYA, S ;
YOUNG, NS .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (05) :1034-1044
[5]   ANTIGENIC PARVOVIRUS B19 COAT PROTEINS VP1 AND VP2 PRODUCED IN LARGE QUANTITIES IN A BACULOVIRUS EXPRESSION SYSTEM [J].
BROWN, CS ;
SALIMANS, MMM ;
NOTEBORN, MHM ;
WEILAND, HT .
VIRUS RESEARCH, 1990, 15 (03) :197-211
[6]   LOCALIZATION OF AN IMMUNODOMINANT DOMAIN ON BACULOVIRUS-PRODUCED PARVOVIRUS B19-CAPSIDS - CORRELATION TO A MAJOR SURFACE REGION ON THE NATIVE VIRUS PARTICLE [J].
BROWN, CS ;
JENSEN, T ;
MELOEN, RH ;
PUIJK, W ;
SUGAMURA, K ;
SATO, H ;
SPAAN, WJM .
JOURNAL OF VIROLOGY, 1992, 66 (12) :6989-6996
[7]   ASSEMBLY OF EMPTY CAPSIDS BY USING BACULOVIRUS RECOMBINANTS EXPRESSING HUMAN PARVOVIRUS-B19 STRUCTURAL PROTEINS [J].
BROWN, CS ;
VANLENT, JWM ;
VLAK, JM ;
SPAAN, WJM .
JOURNAL OF VIROLOGY, 1991, 65 (05) :2702-2706
[8]  
BROWN T, 1984, LANCET, V2, P1033
[9]   DIAGNOSTIC ASSAYS WITH MONOCLONAL-ANTIBODIES FOR THE HUMAN-SERUM PARVOVIRUS-LIKE VIRUS (SPLV) [J].
COHEN, BJ ;
MORTIMER, PP ;
PEREIRA, MS .
JOURNAL OF HYGIENE, 1983, 91 (01) :113-&
[10]  
COLLETTMS, 1994, REV MED VIROL, V4, P91